MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1
Abstract Background: Emerging evidence showed that microRNAs (miRs) play critical roles in human cancers by functioning as either tumor suppressor or oncogene. MIR-382 was found to function as tumor suppressor in certain cancers. However, the role of MIR-382 in colorectal cancer (CRC) is largely un...
Guardado en:
Autores principales: | , , |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2018
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602018000100241 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0716-97602018000100241 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0716-976020180001002412019-06-24MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1Ren,YupengZhang,HaoJiang,Peng MIR-382 SP1 Colorectal cancer Tumor progression Abstract Background: Emerging evidence showed that microRNAs (miRs) play critical roles in human cancers by functioning as either tumor suppressor or oncogene. MIR-382 was found to function as tumor suppressor in certain cancers. However, the role of MIR-382 in colorectal cancer (CRC) is largely unknown. Specificity protein 1 (SP1) is highly expressed in several cancers including CRC and is correlated with poor prognosis, but it is unclear whether or not MIR-382 can regulate the expression of SP1. Methods: MIR-382 expression level was measured by reverse transcription-quantitative polymerase chain reaction. The connection between MIR-382 and SP1 was validated by luciferase activity reporter assay and western blot assay. Cell counting kit-8 assay and wound-healing assay were conducted to investigate the biological functions of MIR-382 in CRC. Results: In this study, we found MIR-382 expression was downregulated in CRC tissues and cell lines, and the transfection of MIR-382 mimic decreased cell growth and migration. Furthermore, we identified SP1 was a direct target of MIR-382. Overexpression of MIR-382 decreased the expression of SP1, whereas MIR-382 knockdown promoted SP1 expression. We also observed an inversely correlation between MIR-382 and SP1 in CRC tissues. Additionally, we showed that knockdown of SP1 inhibited cell growth and migration and attenuated the effect of MIR-382 inhibitor on cell behaviors. Conclusions: In conclusion, the present study describes a potential mechanism underlying a MIR-382/SP1 link contributing to CRC development. Thus, MIR-382 may be able to be developed as a novel treatment target for CRC.info:eu-repo/semantics/openAccessSociedad de Biología de ChileBiological Research v.51 20182018-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602018000100241en10.1186/s40659-018-0200-9 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
English |
topic |
MIR-382 SP1 Colorectal cancer Tumor progression |
spellingShingle |
MIR-382 SP1 Colorectal cancer Tumor progression Ren,Yupeng Zhang,Hao Jiang,Peng MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1 |
description |
Abstract Background: Emerging evidence showed that microRNAs (miRs) play critical roles in human cancers by functioning as either tumor suppressor or oncogene. MIR-382 was found to function as tumor suppressor in certain cancers. However, the role of MIR-382 in colorectal cancer (CRC) is largely unknown. Specificity protein 1 (SP1) is highly expressed in several cancers including CRC and is correlated with poor prognosis, but it is unclear whether or not MIR-382 can regulate the expression of SP1. Methods: MIR-382 expression level was measured by reverse transcription-quantitative polymerase chain reaction. The connection between MIR-382 and SP1 was validated by luciferase activity reporter assay and western blot assay. Cell counting kit-8 assay and wound-healing assay were conducted to investigate the biological functions of MIR-382 in CRC. Results: In this study, we found MIR-382 expression was downregulated in CRC tissues and cell lines, and the transfection of MIR-382 mimic decreased cell growth and migration. Furthermore, we identified SP1 was a direct target of MIR-382. Overexpression of MIR-382 decreased the expression of SP1, whereas MIR-382 knockdown promoted SP1 expression. We also observed an inversely correlation between MIR-382 and SP1 in CRC tissues. Additionally, we showed that knockdown of SP1 inhibited cell growth and migration and attenuated the effect of MIR-382 inhibitor on cell behaviors. Conclusions: In conclusion, the present study describes a potential mechanism underlying a MIR-382/SP1 link contributing to CRC development. Thus, MIR-382 may be able to be developed as a novel treatment target for CRC. |
author |
Ren,Yupeng Zhang,Hao Jiang,Peng |
author_facet |
Ren,Yupeng Zhang,Hao Jiang,Peng |
author_sort |
Ren,Yupeng |
title |
MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1 |
title_short |
MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1 |
title_full |
MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1 |
title_fullStr |
MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1 |
title_full_unstemmed |
MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1 |
title_sort |
microrna-382 inhibits cell growth and migration in colorectal cancer by targeting sp1 |
publisher |
Sociedad de Biología de Chile |
publishDate |
2018 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602018000100241 |
work_keys_str_mv |
AT renyupeng microrna382inhibitscellgrowthandmigrationincolorectalcancerbytargetingsp1 AT zhanghao microrna382inhibitscellgrowthandmigrationincolorectalcancerbytargetingsp1 AT jiangpeng microrna382inhibitscellgrowthandmigrationincolorectalcancerbytargetingsp1 |
_version_ |
1718441578462183424 |